| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/05/2004 | US20040152157 G-protein coupled receptors |
| 08/05/2004 | US20040152143 Growth differentiation factor-9 |
| 08/05/2004 | US20040152139 for diagnosing/treating prostate cancer by administering immunoconjugates; gene expression inhibition; genetic engineering |
| 08/05/2004 | US20040152123 for drug screening enzyme inhibitors for cancer treatments; biochips; genetic engineering |
| 08/05/2004 | US20040152078 Genetic engineering |
| 08/05/2004 | US20040152074 Seroreactive regions on HPV 16 proteins E1 and E2 |
| 08/05/2004 | US20040151782 Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol |
| 08/05/2004 | US20040151733 at least two conjugated antigens that are glycolipid antigen, polysaccharide antigen, mucin antigen, and/or glycosylated mucin antigen and an adjuvant; especially for treating small cell lung cancer |
| 08/05/2004 | US20040151723 specific to cancerous and precancerous lesions of the uterus |
| 08/05/2004 | US20040151717 Use of polyclonal immunoglobulins |
| 08/05/2004 | US20040151713 Cell cycle regulatory factor |
| 08/05/2004 | US20040151690 Block copolymer reduced in impurity content, polymeric carrier, pharmaceutical preparations in polymeric form and process for the preparation of the same |
| 08/05/2004 | US20040151667 Internal image antibodies for optical imaging and therapy |
| 08/05/2004 | US20040151665 Scrrening; separation using cancer cell cytotoxicity; diagnosis, antitumor agents, anticancer agents; administering monoclonal antibodies |
| 08/05/2004 | CA2802143A1 Cancer therapy sensitizer |
| 08/05/2004 | CA2514153A1 Antibody and use thereof |
| 08/05/2004 | CA2514108A1 Drugs containing galectin 9 |
| 08/05/2004 | CA2514052A1 Activation and expansion of t cells |
| 08/05/2004 | CA2513881A1 Immunomodulatory compositions |
| 08/05/2004 | CA2513772A1 Cancerous disease modifying antibodies |
| 08/05/2004 | CA2513714A1 Medicament and use thereof for tumor therapy |
| 08/05/2004 | CA2513246A1 Carbamic acid compounds comprising an ester or ketone linkage as hdac inhibitors |
| 08/05/2004 | CA2488677A1 Method of inhibiting prostate cancer cell proliferation |
| 08/04/2004 | EP1443112A2 Macrophage activating factors derived from cloned vitamin D binding protein |
| 08/04/2004 | EP1443110A2 Human VEGF-specific antisense oligonucleotides |
| 08/04/2004 | EP1443106A1 Somatic cell derived embryonic stem cells and its differentiated cells |
| 08/04/2004 | EP1443053A1 Analgesic antitumor peptide from scorpion and method of producing it |
| 08/04/2004 | EP1442750A1 Treatment of cancer using cytokine-expressing polynucleotides and compositions therefor |
| 08/04/2004 | EP1442744A2 Use of EP4 receptor ligands in the treatment of, inter alia, neuropathic pain and colon cancer |
| 08/04/2004 | EP1442742A1 Apoptosis inducer and method of screening for a substance inhibiting acylated homoserine lactone |
| 08/04/2004 | EP1442143A2 RNA INTERFERENCE MEDIATED INHIBITION OF BCL2 GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 08/04/2004 | EP1442125A2 Chimeric viral vectors for gene therapy |
| 08/04/2004 | EP1442121A2 Isolated peptide of the hepatocyte growth factor and its variants, preparation method and therapeutic use as anti-angiogenic agents |
| 08/04/2004 | EP1442064A2 Kinases and phosphatases |
| 08/04/2004 | EP1442062A2 Methods for the treatment of carcinoma |
| 08/04/2004 | EP1442061A1 Reducing immunogenicities of immunoglobulins by framework-patching |
| 08/04/2004 | EP1442058A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 08/04/2004 | EP1442050A2 Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 08/04/2004 | EP1442046A2 Mammalian c-type lectins |
| 08/04/2004 | EP1442042A1 Polycyclic guanine derivative phosphodiesterase v inhibitors |
| 08/04/2004 | EP1442034A1 Benzimidazole derivatives and their use as kdr protein kinase inhibitors |
| 08/04/2004 | EP1442032A1 Heterocyclic retinoid compounds |
| 08/04/2004 | EP1442030A1 Thiopene- amd thiazolesulfonamides as antineoplastic agents |
| 08/04/2004 | EP1442026A1 Triazole derivatives as cyclooxygenase (cox) inhibitors |
| 08/04/2004 | EP1442024A1 AMINOBENZAMIDE DERIVATIVES AS GLYCOGEN SYNTHASE KINASE 3$g(b) INHIBITORS |
| 08/04/2004 | EP1442019A1 Amide derivatives as glycogen synthase kinase 3-beta inhibitors |
| 08/04/2004 | EP1442018A1 Novel anticancer compounds |
| 08/04/2004 | EP1442015A1 Use of 2-acylindoles in the treatment of tumors |
| 08/04/2004 | EP1441773A1 Pacap compositions and methods for tumor imaging and therapy |
| 08/04/2004 | EP1441772A2 Polymer conjugates of protein kinase c inhibitors |
| 08/04/2004 | EP1441766A2 Antibodies that bind to cancer-associated antigen cd46 and methods of use thereof |
| 08/04/2004 | EP1441764A2 Antigen arrays comprising rankl for treatment of bone disease |
| 08/04/2004 | EP1441759A2 Cellular vaccines comprising adjuvants |
| 08/04/2004 | EP1441758A2 Allogenic vaccine that contains a costimulatory polypeptide-expressing tumor cell |
| 08/04/2004 | EP1441756A1 Psp-94: use for treatment of hypercalcemia and bone metastasis |
| 08/04/2004 | EP1441755A2 Topical use of cytokines and chemokines for the treatment of viral or mykotic skin diseases or tumoral diseases |
| 08/04/2004 | EP1441752A1 Endophilin homologous proteins involved in the regulation of energy homeostasis |
| 08/04/2004 | EP1441748A2 High-concentration protein formulations and method of manufacture |
| 08/04/2004 | EP1441737A1 Staurosporine derivatives as inhibitors of flt3 receptor tyrosine kinase activity |
| 08/04/2004 | EP1441736A2 Use of 7h-pyrrolo[2,3-d]pyrimidine derivatives in the treatment of solid tumor diseases |
| 08/04/2004 | EP1441733A1 Pharmaceutical compositions for the treatment of leukemia comprising dioxolane nucleosides analogs |
| 08/04/2004 | EP1441726A1 Derivatives of phenoxy-n-'4-(isothiazolidin-1,1-dioxid-2yl)pheny!-valerian- acid amide and other compounds as inhibitors of the coagulation factor xa in the treatment of thromboembolic diseases and tumors |
| 08/04/2004 | EP1441725A1 Benzimidazoles and analogues and their use as protein kinases inhibitors |
| 08/04/2004 | EP1441721A2 Use of endothelin receptor antagonists in the treatment of tumour diseases |
| 08/04/2004 | EP1441718A2 Carbinols for the treatment of neuropathic dysfunction |
| 08/04/2004 | EP1441717A1 Combination of an atp-competitive inhibitor of bcr/abl kinase activity and a tyrphostin analog |
| 08/04/2004 | EP1441716A1 Alkane diol derivatives as therapeutic agents for the treatment of bone conditions |
| 08/04/2004 | EP1441715A1 Lipoxins and aspirin-triggered lipoxins and their stable analogs in the treatment of asthma and inflammatory airway diseases |
| 08/04/2004 | EP1441714A2 Combinations comprising a selective cyclooxygenase-2 inhibitor |
| 08/04/2004 | EP1441711A1 Treatment of breast cancer |
| 08/04/2004 | EP1441710A1 Use of n,n-diethyl-2- -4-(phenylmethyl)-phenoxy ethanamine monohydrochloride (dppe) in cancer therapy |
| 08/04/2004 | EP1441704A1 Orodispersible tablet having high homogeneity and the preparation method thereof |
| 08/04/2004 | EP1441697A2 Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease |
| 08/04/2004 | EP1441684A2 Methods and compositions for treating urological disorders using 313, 333, 5464, 18817 or 33524 |
| 08/04/2004 | EP1441683A2 Trisubstituted triazine compounds, and methods for making an using the compounds, which have antitubulin activity |
| 08/04/2004 | EP1368027B1 Use of tryptophan derivatives for the specific cytostatic treatment of serotonin-producing tumors |
| 08/04/2004 | EP1313772B1 New cross-linked derivatives of hyaluronic acid |
| 08/04/2004 | EP1278750B1 Imidazopyrimidine derivatives and triazolopyrimidine derivatives |
| 08/04/2004 | EP1202730B1 Use of ep4 receptor ligands in the treatment of neuropathic pain |
| 08/04/2004 | EP1200444B1 Novel xanthone compounds, their preparation and use as medicament |
| 08/04/2004 | EP1171151A4 Thrombospondin-2 and uses thereof |
| 08/04/2004 | EP1169054B1 Prognosis of ptp lar related diseases |
| 08/04/2004 | EP1165140B1 Adjuvant compositions for enhancing immune responses to polynucleotide-based vaccines |
| 08/04/2004 | EP1150658B1 Method for controlling liposome size |
| 08/04/2004 | EP1143968B9 Composition and methods for administration of water-insoluble paclitaxel derivatives |
| 08/04/2004 | EP1112262B1 Substituted gamma-phenyl-delta-lactones and analogs thereof and uses related thereto |
| 08/04/2004 | EP1071745B1 Process for synthesizing cox-2 inhibitors |
| 08/04/2004 | EP0981542B1 20(s) camptothecin glycoconjugates |
| 08/04/2004 | EP0975665B1 Active substance and composition inhibiting tumorous proliferation in ectoderm derived tissues |
| 08/04/2004 | EP0950059B1 Cyclic sulfone derivatives |
| 08/04/2004 | EP0912571B1 Naphthyridines which affect il-4 and g-csf |
| 08/04/2004 | EP0790835B1 Specific immunotherapy of cancer using a live recombinant bacterial vaccine vector |
| 08/04/2004 | EP0667772B9 Taxanes having an alkyl substituted side-chain and pharmaceutical compositions containing them |
| 08/04/2004 | CN1518598A Serpin in Bifidobacteria |
| 08/04/2004 | CN1518595A 修饰的精氨酸脱亚胺酶 Modified arginine deiminase |
| 08/04/2004 | CN1518573A Block copolymer reduced in impurity content, polymeric carrier, pharmaceutical preparations in polymeric form and process for preparation of the same |
| 08/04/2004 | CN1518559A VHH single heavy chain antibody and method for its preparation in mammal |
| 08/04/2004 | CN1518552A Pyrrolopyrimidines as protein kinase inhitibors |
| 08/04/2004 | CN1518551A Triazaspiro [5,5] undecane derivatrives and drugs containing the same as active ingredient |
| 08/04/2004 | CN1518549A Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same |